Sarvbio Labs

Sarvbio Labs is a research-driven biotechnology company based in Hyderabad, India, specializing in the development and manufacturing of high-quality biologics and biosimilars. The company focuses on addressing unmet medical needs in oncology and immunology by leveraging its proprietary Sarv-Express platform for rapid, high-titer cell line development. Sarvbio's pipeline includes several monoclonal antibody biosimilars targeting major therapeutic markers such as TNF-alpha and VEGF, aimed at providing cost-effective treatment options for global markets. Their state-of-the-art R&D and pilot manufacturing facilities support end-to-end development from molecular cloning to process scale-up. By combining technical expertise in protein engineering with efficient manufacturing processes, Sarvbio Labs aims to become a significant player in the global biopharmaceutical landscape.